--2024/Q4-- / 10.501M--
--2024/Q3-- / 10.266M--
Aug 8, 20242024/Q26.957M / 18.249M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 22.380
- +1.070+5.02%
Close Aug 8 16:00 ET
- 22.500
- +0.120+0.54%
Post 19:59 ET
2.27BMarket Cap-4083P/E (TTM)
22.390High20.800Low1.56MVolume22.080Open21.310Pre Close34.22MTurnover1.64%Turnover RatioLossP/E (Static)101.58MShares39.14052wk High2.34P/B2.13BFloat Cap19.37052wk Low--Dividend TTM95.24MShs Float202.730Historical High--Div YieldTTM7.46%Amplitude9.180Historical Low21.881Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Earnings Date
Currency: USD
Period
Q2 FY2024 Earnings
Aug 8, 2024
Revenue(YoY)
6.96M
-48.82%EPS(YoY)
-1.52
-8.57%Analyst Rating
Aug 8, 2024
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
